Allergan receives subpoena over its anti-obesity device

Previous Post: nbsp

Allergan receives subpoena over its anti-obesity device

Reuters – U.S. healthcare group Allergan has received a subpoena from the U.S. government over its gastric banding system that is used to treat obesity. In a filing with the U.S. Securities and Exchange Commission (SEC) on Monday Allergan said the subpoena from the Department of Health and Human Services, Office of the Inspector General, requests the production of documents relating to its Lap-Band gastric banding system. Read article

Tags: ,

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes